Dishman Pharmaceuticals & Chemicals Limited (DPCL) along with promoters of DPCL and group/associate companies and other investors would be the main promoters. Dishman group comprises of different companies of which following are the main operating companies :

• Dishman Pharmaceuticals & Chemicals Ltd. (DPCL).
• Schutz Dishman Biotech Limited (SDBL)
• B.R.Laboratories (BRL).

DPCL, Flagship Listed Public Company, is engaged in manufacturing of Speciality Chemicals, Active Pharmaceutical Ingredients & Intermediates and offers services

such as Contract Research Outsourcing (CRO) & Contract Manufacture, Outsourcing (CMO). DPCL has world-wide presence through subsidiaries in UK, USA, Netherlands, Switzerland , UAE, China and Joint Ventures in Saudi Arabia. DPCL has acquired three Contract Research companies in Europe namely, Synprotec based in Manchester, IO3S and Carbogen Amsis based in Switzerland, DPCL's market capitalization is above Rs. 1700 crores.

DPCL has global experience of 20 years of establishing and managing pharma and fine chemicals business quite successfully. The exposure and experience of establishing chemical / pharma units spread over 80 Ha. area has equipped DPCL with basic insights and capabilities to create, maintain and manage manufacturing facilities, infrastructures and to preserve environment by following best practices for effluent treatment and pollution control. This is further evident from the fact that DPCL facility at Bavla is USFDA approved and the Schutz Dishman Biotech facility at Bavla is EDQM approved. The promoters have required strengths and confidence to arrange or raise required Financial and other resources to create, implement and manage the SEZ.